Changes in body composition in women treated with gonadotropin-releasing hormone agonists.
The changes that agonists of gonadotropin-releasing hormone (GnRH) produce in mineral bone mass are known, but, as far as we know, those produced by these agents in other body compartments are unknown. We studied these changes using dual-energy X-ray absorptiometry in 50 eugonadal women treated with decapeptyl (Triptoreline), 3.75 mg injected intramuscularly, at 28-day intervals for 6 months. There were significant increases in fat content (9.5%, P < 0.0005) and weight (1.3%, P < 0.01), and significant decreases in fat-free mass (-1.9%, P < 0.0001) and water content (-1.8%, P < 0.0002). Bone mass was lost in the axial skeleton (-3.6%, P < 0.0001) but not in the peripheral skeleton. The changes induced in body composition by the GnRH agonists are similar to those of natural menopause.